{"id":"W2245359169","doi":"10.1200/jco.2013.31.4_suppl.337","title":"Bevacizumab (bev) in combination with capecitabine (cape) for the first-line treatment of elderly patients with metastatic colorectal cancer (mCRC): Results of a randomized international phase III trial (AVEX).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Capecitabine; Hazard ratio; Bevacizumab; Clinical endpoint; Internal medicine; Colorectal cancer; Confidence interval; Randomized controlled trial; Cancer; Cape; Surgery; Oncology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001141972,0.0001835735,0.002529928,0.0001495417,0.0000403011,0.000006410795,0.0001078731,0.00009065845,0.00008669266],"category_scores_gemma":[0.001520857,0.00007977393,0.0004378461,0.0001491922,0.0003526616,0.0001021885,0.00001698132,0.0001769136,3.595231e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003595794,"about_ca_system_score_gemma":0.0007552333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007480468,"about_ca_topic_score_gemma":0.003004656,"domain_scores_codex":[0.9963458,0.0002125112,0.002652379,0.0001769705,0.0004496284,0.0001626883],"domain_scores_gemma":[0.9898837,0.005530194,0.002864762,0.0001094696,0.001520388,0.0000915268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8538798,0.01327313,0.004275214,0.00001945119,0.003624718,0.00001844623,0.0006190609,0.00006398236,0.000007062954,0.00001981597,0.000195633,0.1240037],"study_design_scores_gemma":[0.8207392,0.1407674,0.03387366,0.0001213354,0.001820743,0.000009716966,0.0001714457,0.0007263072,0.00006244692,0.00008501454,0.001558648,0.00006409414],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9877995,0.0004279613,0.0001588474,0.006960743,0.0006419651,0.003722311,0.00006710602,0.000002811042,0.0002187335],"genre_scores_gemma":[0.9970176,0.001039115,0.0009832067,0.00009256604,0.0002228416,0.0004997628,0.00002641509,0.00001287252,0.0001056262],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1274943,"threshold_uncertainty_score":0.3253086,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06477086103378332,"score_gpt":0.4269228190159641,"score_spread":0.3621519579821808,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}